Evidence map›Paper›PMID 41132537›Full record

ArticleFrontiers in pharmacology2025

Xiaojia Liu, Ling Wang, Bing Huang, Yi Jiao, Yaqun Guan, Rebiya Nuli

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Gut microbial allies and adversaries in SARS-CoV-2 infection.Current research in microbial sciences · 2026
    Article
  3. Article
  4. A Novel Blend ofFoods (Basel, Switzerland) · 2026
    Article
  5. Viable and Heat-InactivatedMicroorganisms · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaojia LiuDepartment of Human Parasitology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
Ling WangDepartment of Human Parasitology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
Bing HuangDepartment of Human Parasitology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
Yi JiaoDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
Yaqun GuanDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
Rebiya NuliDepartment of Human Parasitology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Impaired glucose regulation (IGR) is a prediabetic state closely associated with gut microbiota dysbiosis. Our previous metagenomic analysis identified a significant deficiency of Methods: A mouse model of IGR was established by HFD. The treatment group received a daily supplementation of live Results: Daily supplementation with Discussion: These findings suggest that intestinal probiotics

Indexed as

Barnesiella intestinihominisgut microbiotaimpaired glucose regulationinsulin resistanceintestinal barrier

Identifiers

PMID41132537
PMCPMC12540160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.